MX343566B - Composiciones y probioticos/prebioticos anticaries. - Google Patents

Composiciones y probioticos/prebioticos anticaries.

Info

Publication number
MX343566B
MX343566B MX2013002247A MX2013002247A MX343566B MX 343566 B MX343566 B MX 343566B MX 2013002247 A MX2013002247 A MX 2013002247A MX 2013002247 A MX2013002247 A MX 2013002247A MX 343566 B MX343566 B MX 343566B
Authority
MX
Mexico
Prior art keywords
strains
prebiotics
probiotics
relates
caries
Prior art date
Application number
MX2013002247A
Other languages
English (en)
Other versions
MX2013002247A (es
Inventor
Obrador Alejandro Mira
Original Assignee
Centro Superior De Investig En Salud Publica (Csisp) *
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centro Superior De Investig En Salud Publica (Csisp) * filed Critical Centro Superior De Investig En Salud Publica (Csisp) *
Publication of MX2013002247A publication Critical patent/MX2013002247A/es
Publication of MX343566B publication Critical patent/MX343566B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L3/00—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12J—VINEGAR; PREPARATION OR PURIFICATION THEREOF
    • C12J1/00—Vinegar; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P39/00—Processes involving microorganisms of different genera in the same process, simultaneously
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A61K38/1729—Cationic antimicrobial peptides, e.g. defensins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4723—Cationic antimicrobial peptides, e.g. defensins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/46—Streptococcus ; Enterococcus; Lactococcus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
    • Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Toxicology (AREA)
  • Communicable Diseases (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)

Abstract

La presente invención se refiere a diferentes cepas bacterianas específicas aisladas de individuos sin caries y que se caracterizan por presentar actividad inhibitoria frente a organismos cariogénicos. La invención describe también un procedimiento de aislamiento de dichas cepas, así como de péptidos bioactivos, tipo péptidos antimicrobianos de origen humano y bacteriano, que también muestran actividad anticañogénica. Además, en la presente invención también se describen composiciones farmacéuticas y/o probióticas/prebióticas, alimentos funcionales, enjuagues bucales, pasta de dientes, chicles, etc, que comprenden al menos una de las cepas y/o al menos uno de los péptidos bioactivos descritos en la invención, o una combinación de los mismos y que son útiles para el tratamiento y/o prevención de enfermedades infecciosas de la cavidad bucal, preferentemente, de la caries.
MX2013002247A 2010-08-31 2011-08-31 Composiciones y probioticos/prebioticos anticaries. MX343566B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES201031302 2010-08-31
PCT/ES2011/070609 WO2012028759A2 (es) 2010-08-31 2011-08-31 Composiciones y probióticos/prebióticos anticaries

Publications (2)

Publication Number Publication Date
MX2013002247A MX2013002247A (es) 2013-07-03
MX343566B true MX343566B (es) 2016-11-09

Family

ID=44936297

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013002247A MX343566B (es) 2010-08-31 2011-08-31 Composiciones y probioticos/prebioticos anticaries.

Country Status (14)

Country Link
US (1) US9629883B2 (es)
EP (1) EP2612904B1 (es)
JP (1) JP5921546B2 (es)
KR (1) KR101739802B1 (es)
CN (1) CN103119153B (es)
AU (1) AU2011298235B2 (es)
BR (1) BR112013004702A2 (es)
CA (1) CA2808793C (es)
ES (1) ES2608577T3 (es)
IL (1) IL224767A (es)
MX (1) MX343566B (es)
PL (1) PL2612904T3 (es)
RU (1) RU2650866C2 (es)
WO (1) WO2012028759A2 (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10206959B2 (en) 2013-02-14 2019-02-19 University Of Florida Research Foundation, Inc. Probiotic arginolytic oral compositions and methods of making and using probiotic arginolytic oral compositions
EP2956130A4 (en) * 2013-02-14 2016-08-31 Univ Florida PROBIOTIC ARGINOLYTIC ORAL COMPOSITIONS AND METHOD FOR THE PREPARATION AND USE OF PROBIOTIC ARGINOLYTIC ORAL COMPOSITIONS
CN108350502B (zh) * 2015-09-09 2022-07-22 普梭梅根公司 用于口腔健康的源自微生物群系的诊断及治疗方法和系统
CN105193857A (zh) * 2015-09-25 2015-12-30 南昌大学 一种人工培养口腔细菌移植在口腔疾病治疗中的应用
CN105193859A (zh) * 2015-09-25 2015-12-30 南昌大学 一种天然口腔细菌移植在口腔疾病治疗中的应用
EP3196318A1 (en) 2016-01-19 2017-07-26 Symrise AG Probiotics for altering the composition of oral biofilms
EP3545110B1 (en) 2016-11-24 2020-11-04 Servizo Galego de Saúde (SERGAS) Antimicrobial strain
EP3351259A1 (en) 2017-01-18 2018-07-25 Symrise AG Probiotics for aggregation with disease-associated species in the oral cavity
US10733214B2 (en) 2017-03-20 2020-08-04 International Business Machines Corporation Analyzing metagenomics data
CN107460150B (zh) * 2017-09-18 2020-03-24 沈阳医学院 Dentisani链球菌及其应用和应用其的产品
CN107557317B (zh) * 2017-09-20 2020-03-24 沈阳医学院 缓症链球菌及其应用和应用其的产品
IL293620A (en) * 2019-12-06 2022-08-01 Forsyth Dental Infirmary For Children Methods and preparations for the prevention and treatment of tooth decay
CN112011627B (zh) * 2020-09-27 2022-02-25 赤峰家育种猪生态科技集团有限公司 与加系大白猪背膘厚相关的分子标记及筛选方法和应用
CN114317783B (zh) * 2021-12-08 2023-07-28 上海锐翌医学检验实验室有限公司 龋齿标志微生物及其应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1321962C (en) 1985-03-20 1993-09-07 Aizo Matsushiro Dental caries preventive preparations and method for preparing said preparations
US5607672A (en) * 1995-06-07 1997-03-04 University Of Florida Research Foundation, Inc. Replacement therapy for dental caries
KR100266752B1 (ko) * 1997-08-07 2001-03-02 오종석 인체 구강내 치태형성을 억제하는 신규한 유산균
US20030077814A1 (en) * 1997-08-07 2003-04-24 Oh Jong Suk Novel lactic acid bacteria
JP2002000261A (ja) * 2000-06-28 2002-01-08 Ozeki Corp 防菌剤
DE60332101D1 (de) * 2002-02-22 2010-05-27 Blis Technologies Ltd Antimikrobielle zusammensetzung
JP4181806B2 (ja) 2002-07-10 2008-11-19 シャープ株式会社 印刷版、印刷機および印刷方法ならびに液晶機器の製造装置および製造方法
US20060258596A1 (en) * 2003-02-14 2006-11-16 Walsh Timothy R Antimicrobial agents
PL1659885T3 (pl) 2003-08-11 2013-06-28 Oragenics Inc Kompozycje do utrzymania zdrowia jamy ustnej
EP1634948A1 (en) * 2004-09-10 2006-03-15 Basf Aktiengesellschaft Means and methods for preventing and/or treating caries
EP1978979B1 (en) 2006-01-04 2014-08-13 Wikström, Maude Probiotic oral health promoting product

Also Published As

Publication number Publication date
RU2013114313A (ru) 2014-10-10
WO2012028759A2 (es) 2012-03-08
RU2650866C2 (ru) 2018-04-17
EP2612904B1 (en) 2016-09-21
MX2013002247A (es) 2013-07-03
JP5921546B2 (ja) 2016-05-24
CN103119153B (zh) 2016-03-23
ES2608577T3 (es) 2017-04-12
JP2013543374A (ja) 2013-12-05
KR20140001832A (ko) 2014-01-07
CN103119153A (zh) 2013-05-22
PL2612904T3 (pl) 2017-07-31
BR112013004702A2 (pt) 2018-09-04
CA2808793C (en) 2020-09-22
EP2612904A2 (en) 2013-07-10
AU2011298235B2 (en) 2016-07-21
AU2011298235A1 (en) 2013-04-18
US20140147426A1 (en) 2014-05-29
US9629883B2 (en) 2017-04-25
WO2012028759A3 (es) 2012-08-02
IL224767A (en) 2017-02-28
KR101739802B1 (ko) 2017-05-25
CA2808793A1 (en) 2012-03-08

Similar Documents

Publication Publication Date Title
AU2011298235B2 (en) Anticaries compositions and probiotics/prebiotics
EP2371347A3 (en) Oral care compositions
WO2008140834A3 (en) Novel antimicrobial peptides
WO2012065782A3 (de) Kollagenhydrolysat für die verwendung zur verbesserung der gesundheit der menschlichen haut, haare und/oder nägel
WO2009144458A3 (en) Food product
NZ744342A (en) Probiotics for use as anti-inflammatory agents in the oral cavity
WO2008128115A3 (en) Low-dose doxepin formulations
WO2010000877A3 (en) Formulation with irritation reducing action comprising bisabolol and [6]-paradol
BR112012022040A2 (pt) ''composição monofásica de tratamento oral, produto de tratamento oral e método para o branqueamento e/ou remineralização dos dentes''.
WO2006027248A3 (de) Mund-, zahn- und zahnprothesenpflegemittel enthaltend die plaquebildung inhibierende substanzen
HK1094455A1 (en) Use of lactic acid bacteria for reducing dental caries and bacteria causing dental caries
MY159379A (en) Composition for human and/or animal nutrition, uses thereof and yeasts
WO2012145611A3 (en) Improved stability of peroxide in oral care compositions
EP2347796A3 (en) Composite particles for use in oral hygiene
EP2525805A4 (en) COMPOSITIONS AND METHODS FOR ORAL HYGIENE
WO2013075920A3 (en) An oral care composition comprising polyphenol
WO2011080396A3 (en) Probiotic bifidobacterial composition in accordance with secretor blood group status
WO2005018342A8 (en) Compositions and methods for the maintenance of oral health
WO2011027258A3 (en) Scented capsules
BR112012011099A2 (pt) método para a produção de uma composição de lactobacilo, composição de lactobacilo, produto, uso de uma composição de lactobacilo, e, método para a profilaxia de cárie e/ou remoção de streptococcus mutans da cavidade oral de um ser humano.
WO2010121213A3 (en) Antibacterial compositions
MX2014010143A (es) Terapia de reemplazo para caries dentales.
MX2011009364A (es) Composiciones de goma de mascar que proporcionan perfiles de liberacion de sabores.
WO2009030413A3 (de) Verfahren zur prophylaxe von karies und parodontopathien
WO2011080395A3 (en) Probiotic bifidobacterial composition in accordance with secretor blood group status

Legal Events

Date Code Title Description
FG Grant or registration